Nanomedicine against Alzheimer’s: EU Project B-SMART Releases Animated Clip
So far incurable, neurodegenerative diseases affect over 7 million people in Europe already – a number which is expected to grow rapidly as the population ages. The film uses comprehensible language to explain the project ambitions and potential to a non-scientific audience. The multinational research endeavour B-SMART, which is funded under the EU Framework Programme for Research and Innovation Horizon 2020, aims to discover new ways to treat neurodegenerative diseases through nanotechnological RNA delivery systems targeting the direct cause of the disease instead of its symptoms. In order to achieve these ambitious goals, 9 partners from academia and industry across different European countries have pooled their resources and expertise. The clip is available on the B-SMART website (http://b-smart-project.eu/film) and on YouTube ( https://youtu.be/Bm-xFbSnOeM ). B-SMART has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 721058.
Keywords
neurodegenerative disease, Alzheimer's, Horizon 2020, Nanomedicine, nanocarrier
Countries
Belgium, Germany, Spain, Italy, Netherlands, Norway, United Kingdom